Gd(OH)3 as Modifier of Iron Oxide Nanoparticles—Insights on the Synthesis, Characterization and Stability

IF 2.5 Q3 CHEMISTRY, PHYSICAL
M. G. Montiel Schneider, P. S. Rivero, Guillermo Arturo Muñoz Medina, Francisco H. Sánchez, V. Lassalle
{"title":"Gd(OH)3 as Modifier of Iron Oxide Nanoparticles—Insights on the Synthesis, Characterization and Stability","authors":"M. G. Montiel Schneider, P. S. Rivero, Guillermo Arturo Muñoz Medina, Francisco H. Sánchez, V. Lassalle","doi":"10.3390/colloids7010008","DOIUrl":null,"url":null,"abstract":"Magnetic resonance imaging is one of the most widely used diagnostic techniques, since it is non-invasive and provides high spatial resolution. Contrast agents (CAs) are usually required to improve the contrast capability. CAs can be classified as T1 (or positive) or T2 (or negative) contrast agents. Nowadays, gadolinium chelates (which generate T1 contrast) are the most used in clinical settings. However, the use of these chelates presents some drawbacks associated with their toxicity. Iron oxide magnetic nanoparticles (MNPs) have been extensively investigated as CA for MRI, especially for their capacity to generate negative contrast. The need for more efficient and safer contrast agents has focused investigations on the development of dual CAs, i.e., CAs that can generate both positive and negative contrast with a single administration. In this sense, nanotechnology appears as an attractive tool to achieve this goal. Nanoparticles can be modified not only to improve the contrast ability of the current CAs but also to enhance their biocompatibility, resolving toxicity issues. With the aim of contributing to the field of development of dual T1/T2 contrast agents for MRI, here, we present the obtained results of the synthesis of hybrid nanoparticles composed of magnetite/maghemite and gadolinium hydroxide. Exhaustive characterization work was conducted in order to understand how the hybrid nanoparticles were formed. The nanoparticles were extensively characterized through FTIR and UV–Vis spectroscopy, TEM and SEM microscopy, X-ray diffraction (XRD) analysis, dynamic light scattering, zeta potential, thermogravimetric analysis, energy-dispersive X-ray and vibrating-sample magnetometry. Stabilization studies were carried out to get an idea of the behavior of nanohybrids in physiological media. Special interest was given to the evaluation of Gd3+ leaching. It was found that carbohydrate coating as well as the adsorption of proteins on the surface may improve the stabilization of hybrid nanoparticles.","PeriodicalId":10433,"journal":{"name":"Colloids and Interfaces","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloids and Interfaces","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/colloids7010008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 1

Abstract

Magnetic resonance imaging is one of the most widely used diagnostic techniques, since it is non-invasive and provides high spatial resolution. Contrast agents (CAs) are usually required to improve the contrast capability. CAs can be classified as T1 (or positive) or T2 (or negative) contrast agents. Nowadays, gadolinium chelates (which generate T1 contrast) are the most used in clinical settings. However, the use of these chelates presents some drawbacks associated with their toxicity. Iron oxide magnetic nanoparticles (MNPs) have been extensively investigated as CA for MRI, especially for their capacity to generate negative contrast. The need for more efficient and safer contrast agents has focused investigations on the development of dual CAs, i.e., CAs that can generate both positive and negative contrast with a single administration. In this sense, nanotechnology appears as an attractive tool to achieve this goal. Nanoparticles can be modified not only to improve the contrast ability of the current CAs but also to enhance their biocompatibility, resolving toxicity issues. With the aim of contributing to the field of development of dual T1/T2 contrast agents for MRI, here, we present the obtained results of the synthesis of hybrid nanoparticles composed of magnetite/maghemite and gadolinium hydroxide. Exhaustive characterization work was conducted in order to understand how the hybrid nanoparticles were formed. The nanoparticles were extensively characterized through FTIR and UV–Vis spectroscopy, TEM and SEM microscopy, X-ray diffraction (XRD) analysis, dynamic light scattering, zeta potential, thermogravimetric analysis, energy-dispersive X-ray and vibrating-sample magnetometry. Stabilization studies were carried out to get an idea of the behavior of nanohybrids in physiological media. Special interest was given to the evaluation of Gd3+ leaching. It was found that carbohydrate coating as well as the adsorption of proteins on the surface may improve the stabilization of hybrid nanoparticles.
Gd(OH)3作为氧化铁纳米粒子的改性剂——合成、表征和稳定性的研究进展
磁共振成像是应用最广泛的诊断技术之一,因为它是非侵入性的,并提供高空间分辨率。通常需要造影剂(CA)来提高对比能力。CA可分为T1(或阳性)或T2(或阴性)造影剂。如今,钆螯合物(产生T1对比度)在临床环境中使用最多。然而,这些螯合物的使用存在与其毒性相关的一些缺点。氧化铁磁性纳米颗粒(MNPs)作为MRI的CA,特别是其产生负对比度的能力,已被广泛研究。对更有效和更安全的造影剂的需求集中在双CA的发展上,即单次给药即可产生阳性和阴性对比的CA。从这个意义上说,纳米技术似乎是实现这一目标的一种有吸引力的工具。纳米颗粒的改性不仅可以提高现有CA的对比能力,还可以增强其生物相容性,解决毒性问题。为了促进MRI双T1/T2造影剂的开发,本文介绍了由磁铁矿/磁赤铁矿和氢氧化钆组成的杂化纳米颗粒的合成结果。为了了解杂化纳米颗粒是如何形成的,进行了详尽的表征工作。通过FTIR和UV–Vis光谱、TEM和SEM显微镜、X射线衍射(XRD)分析、动态光散射、ζ电位、热重分析、能量色散X射线和振动样品磁强计对纳米颗粒进行了广泛的表征。进行了稳定性研究,以了解纳米杂化物在生理介质中的行为。对Gd3+浸出的评价给予了特别的关注。研究发现,碳水化合物涂层以及蛋白质在表面的吸附可以提高杂化纳米颗粒的稳定性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Colloids and Interfaces
Colloids and Interfaces CHEMISTRY, PHYSICAL-
CiteScore
3.90
自引率
4.20%
发文量
64
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信